Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach**
Milan Senćanski, Vladimir Perović, Jelena Мilićević, et al.
ChemistryOpen (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 17

Showing 17 citing articles:

Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz
Bioorganic Chemistry (2023) Vol. 135, pp. 106390-106390
Open Access | Times Cited: 23
In silico study unfolds inhibitory potential of epicatechin gallate against SARS-CoV-2 entry and replication within the host cell
Prem Rajak, Abhratanu Ganguly
Mechanobiology in Medicine (2023) Vol. 1, Iss. 2, pp. 100015-100015
Open Access | Times Cited: 8
Exploring the Antiviral Potential of Natural Compounds against Influenza: A Combined Computational and Experimental Approach
Vladimir Perović, Kristina Stevanović, Natalya Bukreyeva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4911-4911
Open Access | Times Cited: 2
Molecular docking-based virtual screening and computational investigations of biomolecules (curcumin analogs) as potential lead inhibitors for SARS-CoV-2 papain-like protease
Taufik Muhammad Fakih, Ritmaleni Ritmaleni, Rahadian Zainul, et al.
Pharmacia (2024) Vol. 71, pp. 1-19
Open Access | Times Cited: 2
In Silico and In Vitro Inhibition of SARS-CoV-2 PLpro with Gramicidin D
Sara Protić, Nevena Kaličanin, Milan Senćanski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1955-1955
Open Access | Times Cited: 6
Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 568-568
Open Access | Times Cited: 5
Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor
Sebastjan Kralj, Marko Jukić, Miha Bahun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 169-169
Open Access | Times Cited: 1
On the dual role of (+)-catechin as primary antioxidant and inhibitor of viral proteases
Giada Ciardullo, Carla Orlando, Nino Russo, et al.
Computers in Biology and Medicine (2024) Vol. 180, pp. 108953-108953
Open Access | Times Cited: 1
SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment
Sara Protić, Milica Crnoglavac Popović, Nevena Kaličanin, et al.
ChemistryOpen (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 1
Affinity of Drug Candidates Binding to SARS CoV-2 PLpro Assessed Using a Generalized-ensemble Method
M Muramoto, Simon Hikiri, Suzuka Saito, et al.
Research Square (Research Square) (2024)
Closed Access
Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
Marcel Arruda Diogo, Augusto Gomes Teixeira Cabral, Renata Barbosa de Oliveira
Pathogens (2024) Vol. 13, Iss. 10, pp. 825-825
Open Access
Integrated Computational and Experimental Approaches to Identify New Papain-Like Protease Inhibitors
Rahul Singh, Amit Dhiman, Mahima Chauhan, et al.
Journal of Molecular Structure (2024), pp. 140460-140460
Closed Access
Screening for Potential Antiviral Compounds from Cyanobacterial Secondary Metabolites Using Machine Learning
Tingrui Zhang, G. X. Sun, Xueyu Cheng, et al.
Marine Drugs (2024) Vol. 22, Iss. 11, pp. 501-501
Open Access
Combining computational and experimental evidence on the activity of antimalarial drugs on papain‐like protease of SARS‐CoV‐2: A repurposing study
Giovanni Ribaudo, Xiaoyun Yun, Alberto Ongaro, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 4, pp. 809-818
Closed Access | Times Cited: 3
Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches
Abbas Khan, Ayesha Liaqat, Adan Masood, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 10, pp. 101775-101775
Open Access
<i>In Silico</i> Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease
Kazunori Miwa, Yan Guo, Masayuki Hata, et al.
Chemical and Pharmaceutical Bulletin (2023) Vol. 71, Iss. 12, pp. 897-905
Open Access
Page 1

Scroll to top